EDGAR Filing Documents for 0001493152-20-004577

Form 8-K - Current report:

SEC Accession No. 0001493152-20-004577

Filing Date

2020-03-24

Accepted

2020-03-24 09:21:55

Documents

Period of Report

2020-03-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	50975
2		ex3-1.htm	EX-3.1	109134
3		ex10-1.htm	EX-10.1	228167
4		ex10-2.htm	EX-10.2	52430
5		ex10-3.htm	EX-10.3	135773
6		ex10-4.htm	EX-10.4	292456
7		ex99-1.htm	EX-99.1	20626
	Complete submission text file	0001493152-20-004577.txt		890928

Mailing Address 201 GROVE RD THOROFARE NJ 08086

Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698

Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)